SSC
MRK icon

Syverson Strege & Co’s Merck MRK Stock Holding History

Syverson Strege & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$576K Sell
4,483
-135
-3% -$15.8K 0.13% 80
2026
Q1 		$556K Buy
4,618
+476
+11% +$55K 0.13% 68
2025
Q4 		$436K Buy
4,142
+90
+2% +$8.45K 0.1% 83
2025
Q3 		$340K Sell
4,052
-304
-7% -$25K 0.08% 98
2025
Q2 		$345K Buy
+4,356
New +$346K 0.08% 102
2023
Q2 		– Sell
-686
Closed -$73K – 407
2023
Q1 		$73K Buy
686
+3
+0.4% +$324 0.03% 105
2022
Q4 		$75.8K Buy
683
+4
+0.6% +$409 0.03% 106
2022
Q3 		$58K Sell
679
-226
-25% -$20.2K 0.03% 115
2022
Q2 		$82K Buy
905
+233
+35% +$20.7K 0.03% 107
2022
Q1 		$55K Buy
672
+4
+0.6% +$315 0.06% 117
2021
Q4 		$51K Buy
668
+3
+0.5% +$239 0.04% 133
2021
Q3 		$50K Buy
665
+4
+0.6% +$304 0.04% 142
2021
Q2 		$51K Sell
661
-104
-14% -$7.74K 0.05% 132
2021
Q1 		$56K Buy
765
+518
+210% +$38.2K 0.06% 112
2020
Q4 		$19K Buy
+247
New +$18.9K 0.02% 155

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Syverson Strege & Co's MRK Position: Q2 2026 in Review

Syverson Strege & Co reduced its Merck (MRK) stake by 2.9% in Q2 2026, selling an estimated $15.8K and leaving 4,483 shares worth $576K. The position accounts for 0.13% of the portfolio, ranked #80.

Syverson Strege & Co first reported a position in MRK in Q4 2020 and has held it in 15 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Syverson Strege & Co held 4,483 shares of Merck worth $576K as of Q2 2026.
  • Syverson Strege & Co sold 135 Merck shares in Q2 2026, an estimated $15.8K.
  • Merck made up 0.13% of Syverson Strege & Co's portfolio in Q2 2026, its #80 holding.
  • Syverson Strege & Co first reported a position in Merck in Q4 2020 and has held it in 15 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Syverson Strege & Co's 13F filing for Q2 2026, filed 6 Aug 2026.